menu

Persistent Fluid in Wet Age-related Macular Degeneration: Understanding the Disease Pathophysiology

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Persistent Fluid in Wet Age-related Macular Degeneration: Understanding the Disease Pathophysiology

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

How can we individualize treatment for persistent fluid in wet age-related macular degeneration? Here are some key management strategies.

  • Sponsored by

  • Overview

    Persistent fluid can lead to worsening outcomes for patients with wet age-related macular degeneration.1 So which of our patients are at higher risk? And once we identify and diagnose those patients, how can we best manage them and form individualized treatment plans to optimize outcomes? Find out the answers to these and other key questions with Drs. John Kitchens, W. Llyod Clark, and Szilard Kiss in the first episode of this two-part series.

    References:
    1. Kaiser PK, Wykoff CC, Singh RP, et al. Retinal fluid and thickness as measures of disease activity in neovascular age-related macular degeneration. Retina. 2021;41(8):1579-1586.  

    © 2022, Regeneron Pharmaceuticals, Inc. All rights reserved.
    OPH.22.06.0033 09/2022

Schedule25 Sep 2023